Альфа-пвп: описание и особенности

The drug was illegal in only a handful of US states prior to the temporary nationwide ban in 2014. Oral administration results in effects appearing around 15 minutes post-ingestion and lasting up to 6 hours.

Its pharmacological effects are likely mediated by the inhibition of dopamine reuptake via the DAT transporter. Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.

Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours. In New Zealand, it is not explicitly scheduled but treated as a Class C substance due to structural similarity to controlled drugs.

Routes of administration include smoking, snorting (intranasal), injection, and oral ingestion.

It was placed under a temporary nationwide ban in the United States effective February 2014. Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion.

Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters. The visual presentation is typically a loose structure of particles on a neutral background.

Primary causes of death linked to Alpha-PVP use include cardiac infarction and pulmonary edema. Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant.

Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples.

Animal studies indicate that Alpha-PVP induces hyperlocomotion and aberrant or stereotypic behaviors. Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures.

Hypokalemia (low potassium levels) has been observed in cases of Alpha-PVP intoxication. Alpha-PVP is considered a parent compound or closely related to MDPV in structural lineage within the cathinone class.

Selective blockade of catecholamine transporters may increase addiction risk compared to non-selective substances. The substance was marketed as 'legal highs' before being banned in many regions.

The European Union banned Alpha-PVP in 2015.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Alpha-PVP has been associated with fatal incidents in multiple jurisdictions. It acts as a psychostimulant with properties similar to cocaine and MDMA.

Alpha-PVP is often sold as a 'designer drug' or disguised as plant fertilizer, bath salts, or research chemicals.